LENZ Therapeutics, Inc. (NASDAQ:LENZ)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $12.4M
- Net income
- -$140.3M
- Net margin
- -1135.0%
Little or no net debt.
- Total debt
- $122K
- Cash
- $24.2M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $233.3M
- Current liabilities
- $17.2M
- Current ratio
- 13.55
Consumes cash and must keep raising it.
- Operating cash flow
- -$113.9M
- Free cash flow
- -$114.4M
- FCF margin
- -925.8%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 31.4M
- Share growth (1y)
- 10.1%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
LENZ Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 3.38 M | 5.49 M | 1.90 M | 1.59 M | 12.50 M | 5.00 M |
| Revenue Growth (YoY) | -72.93 % | 9.72 % | — | — | — | — |
| Cost of Revenue | 454.00 K | 280.00 K | 1.19 M | 525.00 K | 125.00 K | 19.00 K |
| Gross Profit | 2.93 M | 5.21 M | 714.00 K | 1.06 M | 12.38 M | 4.98 M |
| SG&A Expense | 35.85 M | 39.38 M | 44.85 M | 39.53 M | 27.47 M | 12.78 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 3.79 M | 9.06 M |
| Operating Expenses | 35.85 M | 39.38 M | 44.85 M | 39.53 M | 31.26 M | 21.84 M |
| Operating Income | -32.92 M | -34.17 M | -44.13 M | -38.46 M | -18.89 M | -16.86 M |
| Pretax Income | -30.97 M | -31.91 M | -41.49 M | -35.89 M | -16.70 M | -14.41 M |
| Tax Provision | 0.00 | 3.00 K | 0.00 | 2.00 K | 0.00 | 500.00 K |
| Net Income | -30.97 M | -31.92 M | -41.49 M | -35.90 M | -16.70 M | -14.91 M |
| EPS (Basic) | -0.99 | -1.02 | -1.32 | -1.16 | -0.59 | -0.53 |
| EPS (Diluted) | -0.99 | -1.02 | -1.32 | -1.16 | -0.59 | -0.53 |
| Shares Outstanding | 31.42 M | 31.37 M | 31.35 M | 31.07 M | 28.54 M | 28.08 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.